Intellipharmaceutics International

Intellipharmaceutics International

Intellipharmaceutics International

We operate in the niche market created by the expiration of drug product patents and drug product exclusivity periods.
Type
B2c
Founded
1998
Raised
$4M
Follow us
Alexa global traffic share